Show results for
Refine by
Pancreas Disease Equipment & Supplies
6 equipment items found
Manufactured by:Pharmaq AS - part of Zoetis based inOverhalla, NORWAY
Disease: Pancreas Disease. Oil-based vaccine from PHARMAQ AS (part of Zoetis). Relevant identified uses of the substance or mixture and uses advised against. The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies. ...
Manufactured by:Antibodies Incorporated based inDavis, CALIFORNIA (USA)
Immunoblot against crude membrane fractions from whole mouse (MBM) or rat (RBM) brain and from human cerebral cortex [HBM(Cx)] or hippocampus [HBM(H)] and probed with K91/36 (left) or N52A/42 (right) TC ...
by:Curemark based inRye Brook, NEW YORK (USA)
Patient-centered drug discovery is at the core of what we do at Curemark. We approach neurological disorders from a translational and innovative ...
by:Vertex Pharmaceuticals based inBoston, MASSACHUSETTS (USA)
Cystic fibrosis (CF) is a rare, chronic and life-shortening genetic disease. It’s a progressive, multi-system disease that affects the lungs, liver, gastrointestinal tract, pancreas, sinuses, sweat glands and reproductive tract. In the lungs, this leads to the buildup of abnormally thick, sticky mucus that can cause chronic lung infections ...
by:Genova Diagnostics based inAsheville,, NORTH CAROLINA (USA)
A Non-Invasive Stool Biomarker of Pancreatic Exocrine Function. Pancreatic elastase is a protein-digesting enzyme exclusively produced by the human pancreas, and serves as a non-invasive stool biomarker of pancreatic exocrine function. Pancreatic elastase measured in stool has a strong correlation with the invasive gold-standard test for pancreatic insufficiency and, therefore, is a ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
RIPK3-IN-1 is a RIPK3 type II DFG-out inhibitor with an IC50 of 9.1 nM. RIPK3-IN-1 inhibits RIPK1 and RIPK2 with IC50s of 5.5 and >10 μM. RIPK3-IN-1 is also a c-Met kinase inhibitor with an IC50 of 1.1 ...